Clinical Trial Update: Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 evaluation of a donor testing kit to predict acute graft-versus-host disease in patients receiving peripheral blood stem cell allografts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia in Remission
• Leukemia Biphenotypic in Remission
• Lymphoma in Remission
• Myelodysplastic Syndromes with Stable Blasts
• Non-progressive Myeloproliferative Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Myeloid Leukemia in Remission, Lymphoma in Remission | Phase 2, Phase 3 | Status: UNKNOWN